IMS Health Holdings will own a majority of shares if and when a proposed merger with Quintiles wins regulatory approval. And that ownership is shown in the lineup of the proposed executive lineup for a new company as Quintiles CEO Tom Pike takes on a lesser role.
Pike will serve as vice chairman and president for research and development solutions of the clinical research business, Quintiles and IMS disclosed in a regulatory filing early Monday.
- More coverage: Quintiles COO, 2 board members to leave in merger
Ari Bousbib, currently top executive at IMS, will serve as chairman and CEO of the combined company.
Quintiles and IMS announced the merger – worth more than $17 billion at the time – in May. Once the deal is closed, IMS Health shareholders will own more than 51 percent of the company.
Pike stands to make more than $16 million if he stays with the merged companies through 2017.
Other top officers would include:
- Michael McDonnell, EVP and Chief Financial Officer
- James Erlinger, EVP and General Counsel
- Trudy Stein, EVP and Chief Human Resources Officer
Other leaders beyond Pike include:
- Kevin Knightly, President, Information and Technology Solutions
- José Luis Fernández, President, Global Services
- Jon Resnick, President, Real-World Insights
- Scott Evangelista, President, Contract Sales Organization.
“I am proud to be part of a leadership team with deep industry knowledge, a proven track record of success and a commitment to transforming healthcare for the better,” said Ari Bousbibin a statement. “That commitment extends across the 50,000 talented professionals who will soon become part of one global team. Together, we are making excellent progress on our integration planning and are confident that we will be ready for a strong start on day one of the merger.”
Quintiles (NYSE: Q) is based in Durham.